Table 4.
In vitro pharmacokinetic and physicochemical properties
![]() | ||||||
---|---|---|---|---|---|---|
Compd | R | Mr [Da] | clogP/clogD[a] | PSA [Å2][a] | CLint (m)[b] | PPB [%][b] |
39 | ![]() |
383 | 3.8/1.2 | 68 | 2.0 | ND |
40 | ![]() |
412 | 3.1/1.0 | 62 | ND | ND |
41 | ![]() |
397 | 4.0/1.7 | 59 | 10 | 82 |
42 | ![]() |
399 | 2.7/1.0 | 68 | 7.0 | ND |
43 | ![]() |
385 | 2.8/0.6 | 77 | ND | ND |
44 | ![]() |
397 | 4.0/1.7 | 59 | 12 | 94 |
[a] Polar surface area, calculated partition (clogP) and distribution (clogD) coefficients calculated using StarDrop from Optibrium. [b] CLint (m) [mL min−1 (g liver)−1] and plasma protein binding (PPB) were determined using the protocol described in the Experimental Section; ND=not determined.